MAPT and Alzheimer disease: Since the entire Aβ output of the AβPP-independent pathway is retained intraneuronally, in the second AD stage the rate of iAβ accumulation greatly accelerates and its levels substantially and rapidly increase, which causes, via the cascade involving tau pathology, significant neuronal damage and triggers the initial AD symptoms (red lines).